NM
Neumora Therapeutics, Inc. Common Stock (NMRA)
NASDAQ·Healthcare·Biotechnology
$2.22
-0.23%
Mkt Cap $409.59M
Analyst Ratings
Buy
4
Hold
1
Sell
0
Price Target (12 analysts)
$7.25
Range $6.00 – $8.00
Implied Upside
+227.3%
Consensus $7.25 vs current $2.22